Login / Signup

Role of oral hypoglycaemic drugs in preventing complication in non-alcoholic fatty liver disease with type 2 diabetes mellitus.

Museera ZahidSamia Perwaiz KhanSana ErshadSafia IzharRizwana WarraichAli Asghar
Published in: JPMA. The Journal of the Pakistan Medical Association (2024)
The prevalence of non-alcoholic fatty liver disease with type 2 diabetes was high. Combination of empagliflozin + metformin along with lifestyle modifications was highly effective in reducing fatty changes and the level of liver enzymes.
Keyphrases
  • liver fibrosis
  • risk factors
  • metabolic syndrome
  • cardiovascular disease
  • physical activity
  • weight loss
  • drug induced